Harvey Kaye - Biography

Harvey Kaye (born ) is an American businessman. He is Chairman and CEO of Latitude Solutions, Inc.

Early life

Harvey Kaye was born in Philadelphia, Pennsylvania to working class parents. His father was an upholsterer, and his mother, a homemaker. At age 9, he began studying classical clarinet and continued to age 17. Kaye attended Central High School an all male academic city school. As rock and roll became popular in 1957, he switched to saxophone and formed a band. Kaye performed with many recording stars, including Mel Torme, Wayne Newton, Lionel Hampton, Fats Domino, Maynard Ferguson, Bill Haley & the Comets and The Isley Brothers. He later attended Temple University using the proceeds from his musical performances for tuition.

Career

Kaye worked as a trainee with Robinson & Co., a NYSE firm in Philadelphia. After 9 months of training he became a vice-president and head of Financial Planning. He helped pioneer the concept of Financial “Blueprinting” for asset allocation for clients and suggested financial tax planning solutions. During Kayes’ seven year career at Robinson & Co., he met with George Putnum, Head of Putnum funds, Arnie Ganz, Senior Portfolio Manager of Delaware Fund and Gerald Tsai, head of Fidelity Capital Fund. At the age of 30, Kaye left Robinson to form Delphi Capital Group, a NASD brokerage firm, along with other principles. He became President of , based upon his experience with mutual funds at Robinson & Co. The firm and the fund participated in syndicates which included Loeb, Rhoades & Co., Shearson Lehman Brothers, Bache & Company, and others. From 1983–1993, Kaye was founder, Chairman, and President of ORFA Corporation of America, a NASD National Market environmental technology firm. The Board of Directors included Edward J. McCormack, Jr., three term Attorney General of Massachusetts, Thibaut De St.Phalle, author of a definitive text on the Federal Reserve and Dr. William F. Ballhaus, Jr., former President of Lockheed Martin Corporation. A successful 500 ton per day ORFA plant was built in Philadelphia by Research Cottrell and Fluor Thyssen Industries AG. ORFA’s primary institutional investors was TIAA-CREF (Teachers’ Pension Fund) and Lazard Freres. $100 million in capital was raised with Donaldson, Lufkin & Jenrett as ORFA’s investment banker. Kaye and the Company fought four hostile takeovers, which ended in a race to bankruptcy court to adjudicate control.

In 1998 and 1999 Kaye was a featured speaker at Shearson Lehman Bros. Pollution Control Institution Meeting in New York. Kaye operated as Founder, CEO & President of Gulfstream Capital Group, LC, a merchant banking and financial advisory group. Gulfstream, which has specialized in biotechnology, has assisted several companies in achieving medical breakthroughs in the areas of diabetes, drug discover, nanotechnology, molecular diagnostics, drug deliver and wound care. Gulfstream also has been involved in alternative energy and communications.

Other ventures

Greystone Pharmaceuticals: Kaye was the original investor and advisor to the Company since 1995 and served on the Board until his recent resignation. He was replaced by Dr. Peter Sheehan, Head of Wound Care, Mount Sinai Hospital, New York.

BioForce Nanosciences, Inc.: He has served as a Director, strategic business and financial advisor to the Company. The Company’s Nano eNabler instrument is now being used in labs at Harvard, MIT, Stanford University, Royal Academy of Sciences in Moscow, Johns Hopkins, and Curie Institute in Paris. The eNabler has been used to create breakthroughs in cancer research, cellular biology and drug discovery, worldwide.

Generex Biosciences, Inc.: The company was the first to create the ability to deliver large molecule pharmaceuticals; i.e. insulin, vaccines, hormones, etc. by way of buccal absorption directly to the bloodstream and developed first oral insulin. Kaye assisted the company in becoming public and spent two years working with management as an advisor and Wall St. liaison. This Company also developed a vaccine against SARS, and now is developing a H1N1 (Swine Flu) vaccine.

Latitude Solutions, Inc.: Through Vic Cordell, Kaye became aware of the advantages of partnering with the Super Certified Native American Enterprises, and Canadian First Nations government. Kaye and four other long term business colleagues formed Latitude Solutions, Inc. to be a holding company for three subsidiaries Latitude Clean Tech, Trinity Solutions and GPS Latitude. The U.S. Department of Defense, the U.S. Department of Homeland Security, the Environmental Protection Agency, the U.S. Department of Justice, the U.S. Department of Health and Human Services, the Department of National Defence(Canada), the Royal Canadian Mounted Police, Public Safety Canada Law Enforcement, Emergency medical services and other well-funded, mission critical governmental agencies and commercial interests are direct users of the Company’s technologies and services. Kaye is currently, a board member of Angstrum Technologies, a public company trading on the NASDAQ OTC Bulletin Board and Chairman of the Board of Latitude Solutions, Inc.

Leadership Experience

Kaye at the age of 30, formed a new Broker/Dealer, Delphi Capital Group. His principal responsibilities were involved with the Rittenhouse Fund and to bring opportunities to the firm for financing and investment banking. In 1971, the U.S. Securities and Exchange Commission (SEC) opened its first Philadelphia office. In mid-1971, after successfully completing a NASD audit, the SEC decided to focus its attention on the newest and most active firm in the city, Delphi. After months of investigation, the SEC found two technical violations relating to Kaye and the Rittenhouse Fund. The fund’s bid and asked price was priced manually (computers were not yet used in 1971) by a broker whose job was specifically to do that. The SEC found mathematical errors in pricing on infrequent occasions. Secondly, although it was allowed by prospectus, they found that, under Kaye’s direction, $70,000 worth of stock was purchased from another NY based fund. Kaye’s intent was to use that amount of money in a speculative investment to increase the fund’s performance. The stock purchase did not work out, with the SEC’s position deciding that it was not an appropriate investment for a conservative fund, despite the allowance by prospectus. Kaye’s role as President of the fund, was held responsible for the pricing errors and the choice of the speculative stock purchase. In order to settle the matter in 1974, he agreed to a consent decree, neither admitting nor denying the allegations and the firm reimbursed the $70,000 to the fund. He was given the right to reapply for a broker’s license. During the time the SEC was auditing Delphi and its; principals, it was disclosed that on Kaye’s 1972 tax return there was one stock transaction unreported and that $8,000 in taxes would be due. Subsequently, an amended return was filed and a $100 penalty assessed. In the past 34 years, Kaye’s tax and regulatory record is unblemished.

Charity

Through Gulfstream and his personal efforts, a number of lifesaving advancements have been achieved. Utilizing BioForce Nanosciences' NanoArrayer device, researchers at Johns Hopkins have come to understand the mechanics of how healthy cells are invaded by cancer. Through molecular diagnosis, cystic fibrosis, Down syndrome and other diseases are now being diagnosed.

Personal life

Kaye has two daughters, one of whom has worked with him and his wife for the past 15 years.

Articles